Detection of methylated BCAT1 and IKZF1 after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence

BACKGROUND: The risk of recurrence after completion of curative‐intent treatment of colorectal cancer (CRC) is hard to predict. Post‐treatment assaying for circulating tumor DNA (ctDNA) is an encouraging approach for stratifying patients for therapy, but the prognostic value of this approach is less...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Susanne K., Symonds, Erin L., Roy, Amitesh C., Cornthwaite, Kathryn J., LaPointe, Lawrence C., Young, Graeme P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883422/
https://www.ncbi.nlm.nih.gov/pubmed/35822405
http://dx.doi.org/10.1002/cam4.5008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883422/
https://www.ncbi.nlm.nih.gov/pubmed/35822405
http://dx.doi.org/10.1002/cam4.5008

Ejemplares similares